Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

NeuroPace, Inc.

NPCENASDAQ
Healthcare
Medical - Devices
$14.49
$0.00(0.00%)
U.S. Market is Open • 14:02

NeuroPace, Inc. (NPCE) Stock Overview

Explore NeuroPace, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap477.6M
P/E Ratio-19.83
EPS (TTM)$-0.75
ROE-1.37%
Fundamental Analysis

AI Price Forecasts

1 Month$13.49
3 Months$17.46
1 Year Target$16.66

NPCE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NeuroPace, Inc. (NPCE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.41, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $16.66.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -19.83 and a market capitalization of 477.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.04%
5-Day Change
-1.65%
1-Month Change
-13.20%
3-Month Change
6.22%
6-Month Change
65.59%
Year-to-Date (YTD) Change
-5.47%
1-Year Change
0.77%
3-Year Change
168.54%
5-Year Change
-42.55%
All-Time (Max) Change
-42.55%

Contact Information

650 237 2700
455 North Bernardo Avenue, Mountain View, CA, 94043

Company Facts

1,840 Employees
IPO DateApr 22, 2021
CountryUS
Actively Trading

Frequently Asked Questions